主持完成国家自然科学基金1项(非小细胞肺癌OPN对TAM的功能调控研究编号81201649)；
主持完成天津市科委1项(OPN/CD44在非小细胞肺癌转移中的作用及机制编号11JCYBJC13300)；
主持完成教育部高等学校博士学科点专项科研基金(OPN/CD44信号通路对非小细胞肺癌的趋化作用及机制编号20101202120004)；
发表学术论文10余篇，部分成果先后发表在《Ann Thorac Surg 》和《J Thorac Cardiovasc Surg》等胸外科权威期刊。
近5年发表文章SCI论文：
1.Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.Ann Thorac Surg.2013 Dec;96(6):1943-51.
2.Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014 May 9.
3. Osteopontin-expressing macrophages in non-small cell lung cancer predict survival. Ann Thorac Surg. 2015 Apr;99(4):1140-8. doi: 10.1016/j.athoracsur.2014.11.054. Epub 2015 Feb 26.
4.Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis. Chin Med J (Engl). 2013;126(9):1683-8.
5.Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. World J Surg. 2012,36(2):455-62.
6.CCR1 knockdown suppresses human non-small cell lung cancer cell invasion, J Cancer Res Clin Oncol. 2009 May;135(5):695-701.
7.Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. J Cancer Res Clin Oncol. 2010,136:595-601.
|
